AstraZeneca and Oxford’s COVID-19 vaccine shows promising results
Category: #headlines  By Nikita Chaurasia  Date: 2020-10-27
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

AstraZeneca and Oxford’s COVID-19 vaccine shows promising results
  • The vaccine AZD1222 has reportedly triggered lower adverse response among elderly participants.
     
  • Oxford’s and AstraZeneca’s COVID-19 vaccine could be the first candidate to receive a regulatory approval.

According to reliable sources, Oxford University’s COVID-19 vaccine candidate has displayed favorable results after producing immune response among both younger as well as adult participants.

The vaccine AZD1222, which is developed through a collaboration between University of Oxford and British pharmaceutical giant AstraZeneca plc, has reportedly also triggered lower adverse response among elderly participants, which is not the case with other vaccines under trial.

Sources with knowledge of the matter stated that the positive results emerged in data regarding safety & immune responses of study participants during Oxford’s phase II trials. The data included results of British volunteers of the age group 56-69 as well as that of over 70, which is likely to be formally published in the upcoming weeks.

According to the University of Oxford, the recently acquired results mark a milestone and provide assurance that the vaccine is not only safe to use, but also induces a strong immune response among individuals of all age groups.

It is to be noted that Oxford University and AstraZeneca have been conducting trials of their potential COVID-19 vaccine for months across the globe.

The potential vaccine could be a game changer in the battle against the COVID-19 pandemic, which has killed over 1.15 million people world over. In fact, Oxford’s and AstraZeneca’s COVID-19 vaccine could be the first candidate to receive a regulatory approval along with potential candidates like BioNtech as well as Pfizer.

Matt Hancock, British Health Secretary, was reported saying that although the vaccine is not ready yet, the department is preparing for essential logistics required for a possible roll out, mostly during the first half of the year 2021.

Meanwhile, staff at a major hospital in London have been informed to be prepared to receive the first batch of AstraZeneca and Oxford’s COVID-19 vaccine in first week of November, claimed sources with relevant information.

Source Credits –

https://www.reuters.com/article/us-health-coronavirus-astrazeneca-vaccin/vaccine-hopes-rise-as-oxford-jab-prompts-immune-response-among-old-as-well-as-young-adults-idUSKBN27B0IV

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

U.K.’s competition regulator might look into the music streaming space

U.K.’s competition regulator might look into the music streaming space

By Nikita Chaurasia

The Competition and Markets Authority of the U.K. has revealed plans to launch a probe targeting the country’s music streaming market to ascertain if it is sufficiently consumer-centric and competitive. The announcement came after a U.K. parli...

India’s vaccination drive slows down as dose gap holds back output

India’s vaccination drive slows down as dose gap holds back output

By Nikita Chaurasia

India’s vaccination efforts have reportedly slowed down despite stockpiling vaccines as authorities are maintaining a more than usual gap between two shots. This is a part of the strategy to boost vaccine coverage in the country. The domestic ...

McDonald’s to test McPlant meatless burger at eight U.S. restaurants

McDonald’s to test McPlant meatless burger at eight U.S. restaurants

By Nikita Chaurasia

The McPlant patty is developed in collaboration with Beyond Meat Inc. It will be prepared using vegetarian ingredients like peas, potatoes, and rice. McDonald’s will reportedly start offering its first vegetarian option in the U.S., the ne...